Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Krystal Biotech, Inc.

NASDAQ: KRYS · Life Sciences · 4 alerts · CIK 1711279

Share price
$297.90Close, Nov 16
Market cap
$8.83B
Shares outstanding
29.63MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Krystal Biotech, Inc. filings on SEC EDGAR ↗

7:02 AM ET 8-K
Clinical Trial Data

Krystal Biotech Clinical Trial Data

Krystal Biotech announced positive proof-of-concept clinical data from its Gorlin Syndrome Pilot Study evaluating KB113 for the treatment of basal cell carcinomas. The study showed that over 80% of assessed lesions regressed across three patients, including non-injected lesions, suggesting a systemic abscopal effect.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.